2005/06, Winner, CUEBiC
CamStent
Company Description
Each day, thousands of people suffer from heart attack scaused by underlying coronary artery disease. The condition can be condition can be corrected by angioplasty, followed by wire-mesh stent to hold the artery open, but protein deposition can occlude the stent. Drug-eluting stents attack the deposits, but do not directly address the underlying attachment process.
We propose to create a novel 'non-stick stent, coated with a non-toxic susbstance that is both hydro- and oleo-phobic. We require £1.5m seed funding to reach Phase 1 clinical trial where we can partner with a device manufacturer to capture 15% of this US$15bn market within five years.
Members
Website
m-clic
Company Description
m-clic allows customers to use mobile phones as simple point-and-click payment devices. M-clic offers a secure, standardised and network-independent financial transaction system for mobile devices. Both consumers and merchants are able to use the service immediately without the need for expensive upgrades. We are well positioned to exploit the rapid growth in mobile commerce, which is predicted to become an $88 billion industry by 2009. the m-clic system will run on the majority of current mobile phone handsets and does not require the installation of costly point-of-sale hardware.
Members
Website
MARGO
Company Description
MARGO is a wireless audio high technology and OEM based company based on unique Multi-Channel Audio Restoration technology. MARGO Communications' technology will lead the way to new wireless audio applications. Home theatre, portable audio deveices, digital broadcast, medical hearing devices, military communication devices, and streaming internet music are where MARGO's unique, patented (GB0512397.1) multi-channel audio restoration techniques flourish. MARGO is seeking new investment partners to accelerate the time to bring its superior audio restoration and wireless patent pending prototypes to market as an OEM supplier and to establish additional revenue flow from licenses based on our growing patent portfolio.